Adherence to the evidence-based heart failure drug treatment: Are there sex-specific differences among new users?

The evidence-based heart failure (HF) drug treatment is made of a β-blocker and an angiotensin-converting enzyme inhibitor or an angiotensin II receptor blocker, or hydralazine + isosorbide dinitrate. Little is known about sex-based difference in adherence to the evidence-based HF drug treatment. To...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Research in social and administrative pharmacy 2018-10, Vol.14 (10), p.915-920
Hauptverfasser:	Kayibanda, J.F., Girouard, C., Grégoire, J.-P., Demers, E., Moisan, J.
Format:	Artikel
Sprache:	eng
Schlagworte:	Evidence based drug treatment Heart failure New users Persistence or compliance Sex-based differences
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!